Latest Regulatory News

Race Oncology has raised $3.22 million through a private placement to fund its HARNESS-1 Phase 1a/b trial targeting non-small cell lung cancer, with patient enrolment expected early next year.

Pinnacle Minerals has restarted exploration at its strategically located Adina East Lithium Project in Quebec’s James Bay region, aiming to capitalize on a booming lithium corridor amid rising market prices.

NH3 Clean Energy progresses its WAH2 Project through the FEED phase while forging a pivotal MoU with Japanese giant ITOCHU Corporation to develop clean ammonia bunkering in the Asia Pacific region by 2030.

Lifestyle Communities is extending an option for existing homeowners to adopt a revised Deferred Management Fee model following a pivotal VCAT ruling, aiming to enhance transparency and goodwill regardless of the appeal outcome.

L1 Global Long Short Fund Limited (ASX – GLS) has opened a pro-rata non-renounceable entitlement offer to raise up to A$415 million, marking a pivotal step in its transition to L1 Capital’s Global Long Short Strategy. The offer includes a Top-Up Facility and a subsequent institutional placement to meet strong investor demand.

Summit Minerals has agreed to acquire the historic Keystone Mine in Nevada, a polymetallic project boasting impressive historic grades of silver, gold, and tungsten. The acquisition positions Summit to tap into a prolific US mining district with significant critical metals potential.

Snow Lake Resources has secured a crucial no objection from Australia’s Foreign Investment Review Board for its proposed acquisition of Global Uranium and Enrichment Limited, paving the way for the transaction’s next steps. The independent GUE board unanimously recommends shareholders back the scheme, pending expert endorsement.

Australian Critical Minerals has obtained the final drilling permit for its Flint Project’s Gaya 103 concession in Peru, setting the stage for an imminent diamond drilling campaign targeting a significant high-sulphidation gold-silver system.

Winchester Energy Limited has amended its recent placement announcement, confirming a raise of $350,000 through the issuance of 350 million shares, up from the initially stated $300,000.

Immutep has struck a strategic licensing deal with Dr. Reddy’s, granting rights to commercialise its novel cancer immunotherapy Eftilagimod Alfa across key emerging markets. The agreement includes a $20 million upfront payment and potential milestones exceeding $349 million.

ALS Limited confirms a fully franked ordinary dividend of 19.4 cents per share and announces the Dividend Reinvestment Plan price at $21.97 with no discount applied.

Viridis Mining and Minerals has secured a favorable technical assessment for its Colossus Project's environmental license, setting the stage for a critical council review in December.